TLR9 and cancer: Various cancer cells express high levels of TLR9, e.g. breast and prostate cancer cells (Merrell et al, 2006; Verbaanderd et al, 2017), which is linked to cancer invasiveness in vitro and associated with poor prognosis (Väisänen et al, 2013; Verbaanderd et al, 2017).